Genomics of Rare Hematologic Cancers

The primary aim of this reprint is to describe the genomics of splenic lymphomas, hairy cell leukemia, Cutaneous lymphomas, plasma cell leukemia, MDS with deletion 5q, mastocytosis, hypodiploid acute lymphoblastic leukemia, CLL with complex karyotype and other rare hematologic cancers.

Bibliographic Details
Main Author: Solé, Francesc
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
Online Access:
Collection: Directory of Open Access Books - Collection details see MPG.ReNa
LEADER 01726nma a2200397 u 4500
001 EB002194340
003 EBX01000000000000001331805
005 00000000000000.0
007 cr|||||||||||||||||||||
008 240202 ||| eng
020 |a 9783036589565 
020 |a books978-3-0365-8957-2 
020 |a 9783036589572 
100 1 |a Solé, Francesc 
245 0 0 |a Genomics of Rare Hematologic Cancers  |h Elektronische Ressource 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (278 p.) 
653 |a plasma cell leukemia 
653 |a T cell acute lymphoblastic leukemia 
653 |a Medicine / bicssc 
653 |a germline gene variants in myeloid neoplasmschronic eosinophilic leukemia 
653 |a hairy cell leukemia 
653 |a MALT 
653 |a mastocytosis 
653 |a splenic marginal cell lymphoma 
653 |a GATA2 
653 |a juvenile myelomonocytic leukemia 
700 1 |a Solé, Francesc 
041 0 7 |a eng  |2 ISO 639-2 
989 |b DOAB  |a Directory of Open Access Books 
500 |a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/ 
024 8 |a 10.3390/books978-3-0365-8957-2 
856 4 2 |u https://directory.doabooks.org/handle/20.500.12854/128690  |z DOAB: description of the publication 
856 4 0 |u https://www.mdpi.com/books/pdfview/book/8154  |7 0  |x Verlag  |3 Volltext 
082 0 |a 610 
520 |a The primary aim of this reprint is to describe the genomics of splenic lymphomas, hairy cell leukemia, Cutaneous lymphomas, plasma cell leukemia, MDS with deletion 5q, mastocytosis, hypodiploid acute lymphoblastic leukemia, CLL with complex karyotype and other rare hematologic cancers.